SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694665-20-000090
Filing Date
2020-10-30
Accepted
2020-10-30 08:32:25
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evlo-20200930.htm   iXBRL 10-Q 1513370
2 EX-10.2 exhibit1022020q3.htm EX-10.2 23278
3 EX-10.3 exhibit1032020q3.htm EX-10.3 67597
4 EX-31.1 eveloq32020exhibit311.htm EX-31.1 16317
5 EX-32.1 eveloq32020exhibit321.htm EX-32.1 8197
11 GRAPHIC evelobioseciencesheaderexab.jpg GRAPHIC 4828
  Complete submission text file 0001694665-20-000090.txt   5650976

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20200930.xsd EX-101.SCH 39997
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evlo-20200930_cal.xml EX-101.CAL 65847
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evlo-20200930_def.xml EX-101.DEF 168735
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20200930_lab.xml EX-101.LAB 520511
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20200930_pre.xml EX-101.PRE 309858
12 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20200930_htm.xml XML 709927
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38473 | Film No.: 201274858
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences